Sonic Healthcare Gestione

Gestione criteri di controllo 4/4

Sonic Healthcare's Il CEO è Colin Goldschmidt, nominato in Jan1993, e ha un mandato di 31.58 anni. la retribuzione annua totale è A$ 5.97M, composta da 39.7% di stipendio e 60.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.21% delle azioni della società, per un valore di A$ 27.30M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 27.6 anni e 9.8 anni.

Informazioni chiave

Colin Goldschmidt

Amministratore delegato

AU$5.2m

Compenso totale

Percentuale dello stipendio del CEO	45.9%
Mandato del CEO	31.8yrs
Proprietà del CEO	0.2%
Durata media del management	27.8yrs
Durata media del Consiglio di amministrazione	10yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Colin Goldschmidt rispetto agli utili di Sonic Healthcare?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	AU$5m	AU$2m	AU$511m
Mar 31 2024	n/a	n/a	AU$508m
Dec 31 2023	n/a	n/a	AU$505m
Sep 30 2023	n/a	n/a	AU$595m
Jun 30 2023	AU$6m	AU$2m	AU$685m
Mar 31 2023	n/a	n/a	AU$850m
Dec 31 2022	n/a	n/a	AU$1b
Sep 30 2022	n/a	n/a	AU$1b
Jun 30 2022	AU$8m	AU$2m	AU$1b
Mar 31 2022	n/a	n/a	AU$1b
Dec 31 2021	n/a	n/a	AU$1b
Sep 30 2021	n/a	n/a	AU$1b
Jun 30 2021	AU$7m	AU$2m	AU$1b
Mar 31 2021	n/a	n/a	AU$1b
Dec 31 2020	n/a	n/a	AU$951m
Sep 30 2020	n/a	n/a	AU$739m
Jun 30 2020	AU$4m	AU$2m	AU$528m
Mar 31 2020	n/a	n/a	AU$554m
Dec 31 2019	n/a	n/a	AU$581m
Sep 30 2019	n/a	n/a	AU$565m
Jun 30 2019	AU$6m	AU$2m	AU$550m
Mar 31 2019	n/a	n/a	AU$510m
Dec 31 2018	n/a	n/a	AU$470m
Sep 30 2018	n/a	n/a	AU$473m
Jun 30 2018	AU$5m	AU$2m	AU$476m

Compensazione vs Mercato: La retribuzione totale di Colin ($USD 3.46M ) è circa la media per le aziende di dimensioni simili nel mercato Australian ($USD 2.72M ).

Compensazione vs guadagni: La retribuzione di Colin è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Colin Goldschmidt (70 yo)

31.8yrs

Mandato

AU$5,162,206

Compensazione

Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Colin Goldschmidt	CEO, MD & Executive Director	31.8yrs	AU$5.16m	0.21% A$ 26.8m
Christopher Wilks	Finance Director	31.8yrs	AU$2.39m	0.13% A$ 17.0m
Peter Savage	Chief Business Officer	no data	Nessun dato	Nessun dato
Stephen Fairy	Global Chief Medical Officer	no data	Nessun dato	Nessun dato
David Byrne	Chief Executive Officer of Sonic Healthcare UK	no data	AU$1.07m	Nessun dato
Paul Alexander	Deputy CFO & Company Secretary	23.8yrs	AU$354.42k	Nessun dato
Julian Adler	Chief Executive Officer of Sonic Healthcare Australia - Radiology	4.3yrs	Nessun dato	Nessun dato

27.8yrs

Durata media

65.5yo

Età media

Gestione esperta: Il team dirigenziale di SHL è esperto e expertise (durata media dell'incarico 27.6 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Colin Goldschmidt	CEO, MD & Executive Director	31.8yrs	AU$5.16m	0.21% A$ 26.8m
Christopher Wilks	Finance Director	34.8yrs	AU$2.39m	0.13% A$ 17.0m
Kathryn Spargo	Non-Executive Independent Director	14.3yrs	AU$276.15k	0.0054% A$ 703.3k
Christine Bennett	Independent Non-Executive Director	2.1yrs	AU$224.96k	0.0011% A$ 137.8k
Neville Mitchell	Independent Non-Executive Director	7.1yrs	AU$279.30k	0.0020% A$ 263.9k
Mark Compton	Independent Non-Executive Chairman	10yrs	AU$577.50k	0.0030% A$ 392.6k
Louis Panaccio	Non-Executive Independent Director	19.3yrs	AU$275.10k	0.0017% A$ 217.1k
Katharine Giles	Independent Non-Executive Director	2.1yrs	AU$210.00k	0.00052% A$ 67.6k
Suzanne Crowe	Non-Executive Independent Director	4.5yrs	AU$265.65k	0.0015% A$ 195.0k

10.0yrs

Durata media

67.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di SHL è composto da personale esperto e esperto (durata media dell'incarico 10 anni).

Sonic Healthcare Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Finance Director recently sold AU$1.3m worth of stock

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Recent updates

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Final dividend of AU$0.63 announced

Sonic Healthcare Limited Declares Final Dividend for the Six Months Ended 30 June 2024, Payable on 19 September 2024

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media